HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pieter B van Loenen Selected Research

Pieter B van Loenen Research Topics

Disease

2Fibrosis (Cirrhosis)
02/2021 - 10/2018
1Wounds and Injuries (Trauma)
02/2021
1Myocardial Infarction
02/2021
1Rupture
02/2021
1Cardiomegaly (Heart Hypertrophy)
02/2021
1Heart Failure
10/2018
1Hypertrophy
10/2018
1Thrombosis (Thrombus)
01/2018
1Atherosclerosis
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Edema (Dropsy)
09/2012
1Immune System Diseases (Immune Disorders)
09/2011
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
03/2004
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
03/2004

Drug/Important Bio-Agent (IBA)

2Isoproterenol (Isoprenaline)FDA LinkGeneric
02/2021 - 10/2018
1CollagenIBA
02/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
02/2021
1CalcineurinIBA
10/2018
1Conditioned Culture MediaIBA
10/2018
1Neuropeptide YIBA
10/2018
1BIBO 3304IBA
10/2018
1CatecholaminesIBA
10/2018
1Thromboplastin (Tissue Factor)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1MorpholinosIBA
09/2012
1Fingolimod Hydrochloride (FTY720)FDA Link
09/2011
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
09/2011
1DystrophinIBA
03/2004
1Proteins (Proteins, Gene)FDA Link
03/2004
1Glycoproteins (Glycoprotein)IBA
03/2004